Advertisement · 728 × 90
#
Hashtag
#WuXi_AppTec
Advertisement · 728 × 90
Preview
WuXi AppTec Achieves Exceptional Financial Milestones and Record Performance for 2025 WuXi AppTec has released impressive financial results for 2025, showing substantial growth in revenue and profits. The company's unique CRDMO model drives strong operational performance.

WuXi AppTec Achieves Exceptional Financial Milestones and Record Performance for 2025 #China #Shanghai #WuXi_AppTec #2025_financials #SCRDMO

0 0 0 0
Preview
WuXi AppTec Achieves High Marks for Sustainability from CDP in Climate and Water Security WuXi AppTec, a global leader in pharmaceutical manufacturing, has received double 'A' ratings from CDP for its sustainability initiatives regarding climate change and water security. This recognition highlights its commitment to environmental stewardship.

WuXi AppTec Achieves High Marks for Sustainability from CDP in Climate and Water Security #Sustainability #China #Shanghai #Climate_Change #WuXi_AppTec

2 0 0 0
Preview
WuXi AppTec's Strong Financial Forecasts Indicate Significant Growth Ahead for 2025 WuXi AppTec announces promising projections for 2025, expecting revenue growth of 21.4% and a remarkable rise in net profit, reflecting its commitment to expanding healthcare innovations.

WuXi AppTec's Strong Financial Forecasts Indicate Significant Growth Ahead for 2025 #China #Shanghai #healthcare #WuXi_AppTec #CRDMO

1 0 0 0
Preview
WuXi AppTec Honored as 2025 Global Company of the Year in CRDMO Sector WuXi AppTec has been recognized as the 2025 Global Company of the Year by Frost & Sullivan for its excellence in the CRDMO industry, highlighting its significant innovations and strategies.

WuXi AppTec Honored as 2025 Global Company of the Year in CRDMO Sector #USA #San_Antonio #Frost_&_Sullivan #WuXi_AppTec #CRDMO

0 0 0 0
Preview
WuXi AppTec Achieves Milestone with Frost & Sullivan's 2025 Global Company Award in CRDMO Sector WuXi AppTec has been honored with Frost & Sullivan's 2025 Global Company of the Year Award, marking a significant achievement in the CRDMO industry.

WuXi AppTec Achieves Milestone with Frost & Sullivan's 2025 Global Company Award in CRDMO Sector #China #Shanghai #Frost_&_Sullivan #WuXi_AppTec #CRDMO

0 0 0 0
Preview
WuXi AppTec Expands CRDMO Services into Saudi Arabia with NEOM Partnership WuXi AppTec has signed significant agreements with NEOM and Saudi Arabia's Ministry of Health to expand its CRDMO services into the region, targeting local biopharmaceutical innovation.

WuXi AppTec Expands CRDMO Services into Saudi Arabia with NEOM Partnership #Saudi_Arabia #NEOM #WuXi_AppTec

0 0 0 0
Preview
WuXi AppTec Reports Impressive Double-Digit Growth in Revenue and Profit for Q1-Q3 2025 WuXi AppTec has shown remarkable growth in revenue and profit for the first three quarters of 2025, along with a significant increase in backlog and strong financial performance.

WuXi AppTec Reports Impressive Double-Digit Growth in Revenue and Profit for Q1-Q3 2025 #China #Shanghai #financial_results #WuXi_AppTec #CRDMO

0 0 0 0
Preview
WuXi AppTec Announces Major Cash Dividend Plan to Enhance Shareholder Value WuXi AppTec implements its first interim cash dividend plan, delivering RMB1.03 billion to shareholders, enhancing overall shareholder value for 2024.

WuXi AppTec Announces Major Cash Dividend Plan to Enhance Shareholder Value #China #Shanghai #pharmaceutical #Cash_Dividend #WuXi_AppTec

1 0 0 0
Preview
WuXi AppTec Achieves Gold Medal in EcoVadis Sustainability Rating for the Second Year WuXi AppTec has been awarded the EcoVadis Gold Medal for sustainability efforts for the second consecutive year, showcasing its commitment to eco-friendly practices.

WuXi AppTec Achieves Gold Medal in EcoVadis Sustainability Rating for the Second Year #Sustainability #China #Shanghai #EcoVadis #WuXi_AppTec

0 0 0 0
Preview
WuXi AppTec Completes A-Share Repurchase Program for 2025 to Cancel All Shares WuXi AppTec has successfully finished its A-share repurchase program of RMB1.0 billion in 2025, announcing plans to cancel all repurchased shares to enhance shareholder value.

WuXi AppTec Completes A-Share Repurchase Program for 2025 to Cancel All Shares #China #Shanghai #WuXi_AppTec #A-share_repurchase #stock_value

0 0 0 0
Preview
WuXi AppTec Achieves FTSE4Good Recognition for Sustainable Practices in 2025 In an impressive honor, WuXi AppTec secures its third consecutive year in the FTSE4Good Index, showcasing its strong commitment to sustainability and ESG practices across the pharmaceutical sector.

WuXi AppTec Achieves FTSE4Good Recognition for Sustainable Practices in 2025 #China #Shanghai #ESG_Practices #WuXi_AppTec #FTSE4Good

0 0 0 0
Preview
WuXi AppTec Announces Strategic Share Repurchases and Acquisitions in Q2 2025 WuXi AppTec provides vital updates on its A-share repurchase and H-share acquisition activities, enhancing shareholder value and employee retention.

WuXi AppTec Announces Strategic Share Repurchases and Acquisitions in Q2 2025 #China #Shanghai #stock_repurchase #WuXi_AppTec #H-Share_Acquisition

0 0 0 0
Preview
WuXi AppTec Achieves Prestigious MSCI ESG AAA Leader Recognition WuXi AppTec proudly announces its first MSCI ESG AAA rating, marking a significant achievement in sustainability and corporate governance.

WuXi AppTec Achieves Prestigious MSCI ESG AAA Leader Recognition #Sustainability #China #Shanghai #WuXi_AppTec #MSCI_ESG

0 0 0 0
Preview
WuXi AppTec Nantong Site Wins Prestigious 2025 Architizer A+Award WuXi AppTec's Nantong site has been awarded the Popular Choice Winner at the 2025 Architizer A+Awards, highlighting a unique fusion of technology and humanity.

WuXi AppTec Nantong Site Wins Prestigious 2025 Architizer A+Award #China #WuXi_AppTec #Nantong #Nantong_Site #Architizer_A+

0 0 0 0
Preview
WuXi AppTec Secures SBTi Validation for Ambitious Emissions Targets WuXi AppTec has received SBTi validation for its near-term emissions reduction targets, committing to a significant cut in greenhouse gases by 2030.

WuXi AppTec Secures SBTi Validation for Ambitious Emissions Targets #SBTi #Greenhouse_Gases #WuXi_AppTec

0 0 0 0
Preview
WuXi AppTec's Recognition in Extel's 2025 Asia Leadership Rankings WuXi AppTec has been awarded top honors in Extel's 2025 leadership rankings, affirming its quality service in healthcare and innovation.

WuXi AppTec's Recognition in Extel's 2025 Asia Leadership Rankings #China #Shanghai #WuXi_AppTec #CRDMO #Extel_Rankings

0 0 0 0
Preview
WuXi AppTec Shines in Extel 2025 Asian Executive Rankings, Leading the Healthcare Sector WuXi AppTec has made a remarkable impact by ranking among the top 10 companies in the Extel 2025 Executive Rankings for Asia's healthcare, showcasing its dedication to innovation and quality care.

WuXi AppTec Shines in Extel 2025 Asian Executive Rankings, Leading the Healthcare Sector #Shanghai #None #healthcare #WuXi_AppTec #Extel_Rankings

0 0 0 0
Preview
WuXi AppTec Achieves Top Recognition in Extel 2025 Asia Executive Team Rankings WuXi AppTec has been celebrated as one of the top companies by Extel in its 2025 Asia Executive Team Rankings, showcasing excellence in the pharmaceutical industry.

WuXi AppTec Achieves Top Recognition in Extel 2025 Asia Executive Team Rankings #China #Shanghai #Pharmaceutical_Industry #WuXi_AppTec #Extel_Rankings

0 0 0 0
Preview
WuXi AppTec Achieves Top Recognition in 2025 Asia Executive Team Rankings WuXi AppTec has been awarded top positions in Extel's 2025 Asia Executive Team Rankings, highlighting its impact in the pharmaceutical industry.

WuXi AppTec Achieves Top Recognition in 2025 Asia Executive Team Rankings #China #Shanghai #WuXi_AppTec #CRDMO #Asia_Executive_Team

0 0 0 0
Preview
WuXi AppTec Reports Strong Q1 2025 Financial Results With Remarkable Growth Metrics WuXi AppTec showcases impressive growth for Q1 2025, with total revenue of RMB9.65 billion and adjusted net profit surging 40% YoY. Backlog up by 47%.

WuXi AppTec Reports Strong Q1 2025 Financial Results With Remarkable Growth Metrics #China #Shanghai #Financial_Growth #WuXi_AppTec #Q1_2025

0 0 0 0
Preview
WuXi AppTec's API Sites in China Achieve Outstanding FDA Inspection Results WuXi AppTec has announced that its Changzhou and Taixing API manufacturing sites passed FDA inspections with no observations, demonstrating their commitment to quality standards.

WuXi AppTec's API Sites in China Achieve Outstanding FDA Inspection Results #China #WuXi_AppTec #API_Manufacturing #FDA_Inspections #Changzhou_and_Taixing

0 0 0 0
Preview
WuXi AppTec Reports Record Financial Outcomes Driven by Steady Growth in 2024 WuXi AppTec achieved remarkable revenue and profit growth in 2024, with record highs in Q4. This performance reflects a solid operational strategy, meeting targets while expanding capabilities.

WuXi AppTec Reports Record Financial Outcomes Driven by Steady Growth in 2024 #China #Shanghai #Financial_Performance #revenue_growth #WuXi_AppTec

0 0 0 0
Preview
NAMSA's Strategic Acquisition: Strengthening Medical Device Testing and Consulting Services NAMSA announces its acquisition of WuXi AppTec's U.S. medical device testing business, enhancing its research capabilities and expertise.

NAMSA's Strategic Acquisition: Strengthening Medical Device Testing and Consulting Services #United_States #Medical_Device #WuXi_AppTec #Toledo #NAMSA

0 0 0 0
Preview
WuXi AppTec Partners with PSCI to Enhance Pharmaceutical Supply Chain Responsibility WuXi AppTec has joined the PSCI as a Supplier Partner, emphasizing responsible practices in the pharmaceutical supply chain to promote environmental and social values.

WuXi AppTec Partners with PSCI to Enhance Pharmaceutical Supply Chain Responsibility #China #Shanghai #pharmaceutical #WuXi_AppTec #PSCI

0 0 0 0
Preview
WuXi AppTec Honored for Sustainable Practices by Dow Jones Indices for Fourth Straight Year WuXi AppTec has earned recognition from the Dow Jones Sustainability Indices for its steadfast commitment to sustainability, marking four years in a row.

WuXi AppTec Honored for Sustainable Practices by Dow Jones Indices for Fourth Straight Year #Sustainability #China #Shanghai #DJSI #WuXi_AppTec

0 0 0 0